Elanco Animal Health Inc (ELAN, Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Elanco Animal Health Inc has a market cap of $10.74 billion; its shares were traded at around $29.38 with a P/E ratio of 2938.00 and P/S ratio of 4.53.
For the last quarter Elanco Animal Health Inc reported a revenue of $799.3 million, compared with the revenue of $697.1 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $3.1 billion, an increase of 6.2% from last year.
The reported diluted earnings per share was 28 cents for the year, compared with the loss per share of $0 in the previous year. The Elanco Animal Health Inc had a decent operating margin of 10.23%, compared with the operating margin of 4.93% a year before. The 10-year historical median operating margin of Elanco Animal Health Inc is 4.93%. The profitability rank of the company is 3 (out of 10).
At the current stock price of $29.38, Elanco Animal Health Inc is traded at close to its historical median P/S valuation band of $32.40. The P/S ratio of the stock is 4.53, while the historical median P/S ratio is 4.99.
For the complete 20-year historical financial data of ELAN, click here.
